[Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
D000787:Angina Pectoris / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001161:Arteriosclerosis / Q000188:drug therapy*; D003374:Coumarins / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D014812:Vitamin K; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Le indicazioni dei farmaci anticoagulanti e fibrinolitici nella profilassi e nella terapia delle affezioni tromboemboliche